Adma Biologics ADMA
NASDAQ ADMA
$9.72 -0.21 (-2.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Interest & Investment Income (2011 - 2026)

Updated

Adma Biologics (ADMA) reported Interest & Investment Income of $1.24 million for Q2 2026, up 209.5% from $400,000 a year earlier and up 13.3% from the prior quarter.

Analysis

Adma Biologics (ADMA) Interest & Investment Income (2011 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Adma Biologics' Interest & Investment Income came in at $3.19 million, up 40.6% year-over-year; for FY2025, it was $1.87 million, down 10.8% from FY2024.

  • Interest & Investment Income has a five-year compound annual growth rate of 45.4% (FY2020 to FY2025).
  • By year, Interest & Investment Income came in at $2.1 million in FY2024 (+29.7%), $1.62 million in FY2023, $45,000 in FY2022 (+28.6%) and $35,000 in FY2021 (-87.9%).
  • The Q2 2026 figure ranks as the highest quarterly Interest & Investment Income in data going back to Q1 2011.
  • Year over year, Interest & Investment Income gained in four of the last eight quarters, with growth averaging 41.2%.
  • The high point for year-over-year Interest & Investment Income in five years was Q1 2023 (growth of 402.0%); the low point was Q4 2021 (a decline of 85.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.09 million (Q1 2026), $487,000 (Q4 2025) and $376,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Adma Biologics 2.19 Bn 1.77 Bn 86.28 Mn 1.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.24 Mn
Mar 31, 2026 1.09 Mn
Dec 31, 2025 487,000.00
Sep 30, 2025 376,000.00
Jun 30, 2025 400,000.00
Mar 31, 2025 608,000.00
Dec 31, 2024 598,000.00
Sep 30, 2024 666,000.00
Jun 30, 2024 449,000.00
Mar 31, 2024 384,000.00
Dec 31, 2023 612,000.00
Sep 30, 2023 423,000.00
Jun 30, 2023 414,000.00
Mar 31, 2023 166,000.00
Dec 31, 2022 2,427.00
Sep 30, 2022 7,236.00
Jun 30, 2022 2,269.00
Mar 31, 2022 33,068.00
Dec 31, 2021 2,759.00
Sep 30, 2021 4,256.00
API Access

Adma Biologics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ADMA&period=max&api_key=YOUR_API_KEY